The skin treatment landscape is changing
A few years ago, the typical conversation in a facial plastic surgery practice went something like this: surgery or filler, and which filler. That conversation has expanded.
In 2026, patients are arriving with better questions and more specific goals. They want to know about CO2 laser. They have heard about exosomes. They are reading about bioremodelers and polynucleotides and wondering if those are right for them, or if they are marketing terminology for the same old things.
Some of this is marketing. Some of it is genuinely new and clinically meaningful. Here is a clear look at what is actually worth paying attention to right now.
CO2 Laser Resurfacing: Why It's Having a Moment
CO2 laser resurfacing is not new. What is new is the role it is playing in treatment planning, particularly for patients combining it with surgery or using it as a standalone treatment for skin quality.
The procedure works by delivering precisely controlled laser energy to the skin's surface. This removes damaged outer layers and stimulates collagen remodeling in the deeper layers beneath. The result, over the weeks and months following treatment, is a meaningful improvement in skin texture, tone, fine lines, and pore size.
What is driving renewed interest: patients are increasingly seeking treatments with durable results rather than treatments that require constant maintenance. CO2 laser, unlike most energy-based devices, creates real structural change in the skin. The results last.
For patients who have had or are planning a facelift, CO2 laser is often discussed as a complementary treatment. Surgery repositions the underlying structure; laser improves the surface quality. The two address different problems and work well together.
Recovery from CO2 laser requires real downtime, typically one to two weeks of visible healing. Patients should plan accordingly. The trade-off is results that last years rather than months.
Exosomes and Regenerative Medicine: What to Know
Exosomes are receiving significant attention in facial plastic surgery in 2026, and for good reason. The AAFPRS member survey found that 57% of facial plastic surgeons identify regenerative medicine as a major growth area.
Exosomes are signaling particles derived from stem cells. When applied after a procedure like CO2 laser, microneedling, or even as a standalone treatment, they appear to accelerate healing, reduce inflammation, and stimulate collagen production. The early clinical results are promising, though this area is still evolving.
Dr. Moradi follows the clinical research on regenerative treatments closely, including exosomes, PRP, and biostimulators. When the evidence supports a treatment, it earns a place in the practice. When the evidence is not yet strong enough, that is something patients hear directly. At Moradi MD, regenerative add-ons are discussed in the context of your specific goals, your existing skin condition, and what the current evidence supports.
Bioremodelers and Polynucleotides: The Newer Category
New bioremodeler products, including Profhilo and polynucleotide-based treatments, are expanding into the US market in 2026. These differ from traditional fillers in that they work primarily by stimulating the skin's own collagen and elastin production rather than physically adding volume.
For patients who are not ready for surgery but want a meaningful improvement in skin quality and hydration, bioremodelers represent a category worth exploring. They are not a replacement for surgery when surgery is indicated, but for the right patient at the right stage, they offer a real option.
What sets them apart from the fillers most patients are familiar with: the goal is tissue quality rather than volume. The product is absorbed over time while leaving behind a more resilient skin structure.
What's Actually New in Injectables
Allergan presented updated clinical data at IMCAS 2026, with a focus on longer-lasting, more naturalistic results across its injectable portfolio. Patients will likely arrive at consultations with questions about new filler formulations and neuromodulators.
The short answer: the direction of the industry is toward products that require fewer touch-ups and that integrate more naturally with surrounding tissue. If you have been curious about what has changed in injectables since your last treatment, that is a good conversation to have.
How to Make Sense of It All
Not every patient needs every treatment, and not every new treatment is right for every patient. The most useful thing you can do is have a conversation with a surgeon who follows the research and is not incentivized to oversell.
Dr. Moradi's research background means the clinical conversation at Moradi MD stays anchored to evidence. Whether you are interested in CO2 laser as a standalone treatment, as a complement to surgery, or you want to understand what the regenerative options actually offer, that conversation is worth having in person.
Learn more about skin treatments and what Moradi MD offers at moradimd.com.
To schedule a consultation at our Vista, CA office, call (760) 726-6451.
